Matthew W. Foehr - Aug 4, 2021 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
President and COO
Signature
By: Charles S. Berkman For: Matthew W. Foehr
Stock symbol
LGND
Transactions as of
Aug 4, 2021
Transactions value $
-$677,762
Form type
4
Date filed
8/5/2021, 04:44 PM
Previous filing
Jun 10, 2021
Next filing
Nov 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Options Exercise $194K +8.84K +5.38% $21.92 173K Aug 4, 2021 Direct
transaction LGND Common Stock Sale -$970K -8.84K -5.1% $109.67 164K Aug 4, 2021 Direct F1
transaction LGND Common Stock Options Exercise $98K +1.14K +0.69% $85.79 165K Aug 4, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LGND Employee Stock Option (right to buy) Options Exercise $0 -8.84K -44.2% $0.00 11.2K Aug 4, 2021 Common Stock 8.84K $21.92 Direct F2
transaction LGND Employee Stock Option (right to buy) Options Exercise $0 -1.14K -4.22% $0.00 25.9K Aug 4, 2021 Common Stock 1.14K $85.79 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.06 to $111.00, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/15/13.
F3 Grant to reporting person of options to purchase shares of common stock ("Option Shares"), exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/11/16.